Preparation of EU Application: Innovation in Cell Therapy for Neurodegenerative Diseases
| Reference number | |
| Coordinator | Oscillution AB |
| Funding from Vinnova | SEK 117 460 |
| Project duration | June 2025 - September 2025 |
| Status | Ongoing |
| Venture | Global cooperation 2025 |
| Call | Planning grant for international proposal 2025 |
Purpose and goal
Prepare and submit a competitive application to Horizon Europe. Strengthen consortium partnerships through strategic meetings and collaborative discussions. Optimize the application with professional consultation provided by a consultant firm.
Expected effects and result
The grant is essential not only for delivering high-quality contributions to the EU application but also for securing strategic growth and long-term competitiveness. Once funding is secured and the EU project is executed, this initiative will support Oscillution’s expansion into the growing preclinical testing market, with a focus on safety and efficacy profiling for neuro-cell therapies. It will also enable the company to scale into more established markets within neuroscience drug discovery.
Planned approach and implementation
This planning project aims to support Oscillution AB’s participation in the Horizon Europe call HORIZON-HLTH-2025-01-TOOL-01 through the coordination of consortium meetings and the professional development of the EU application together with a consultant firm. The focus is on strategic coordination, joint planning, and the submission of a high-quality application.